538 related articles for article (PubMed ID: 32345485)
21. Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020.
Harvala H; Mehew J; Robb ML; Ijaz S; Dicks S; Patel M; Watkins N; Simmonds P; Brooks T; Johnson R; Gopal R; Roberts DJ; Zambon M;
Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700670
[TBL] [Abstract][Full Text] [Related]
22. Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
Bradfute SB; Hurwitz I; Yingling AV; Ye C; Cheng Q; Noonan TP; Raval JS; Sosa NR; Mertz GJ; Perkins DJ; Harkins MS
J Infect Dis; 2020 Oct; 222(10):1620-1628. PubMed ID: 32779705
[TBL] [Abstract][Full Text] [Related]
23. Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma.
Lindholm PF; Ramsey G; Kwaan HC
Semin Thromb Hemost; 2020 Oct; 46(7):796-803. PubMed ID: 32526774
[TBL] [Abstract][Full Text] [Related]
24. Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment.
Ouyang J; Isnard S; Lin J; Fombuena B; Peng X; Routy JP; Chen Y
Front Immunol; 2020; 11():570063. PubMed ID: 33072111
[TBL] [Abstract][Full Text] [Related]
25. Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19.
Alzoughool F; Alanagreh L
Int J Risk Saf Med; 2020; 31(2):47-51. PubMed ID: 32310190
[TBL] [Abstract][Full Text] [Related]
26. Convalescent plasma in Covid-19: Possible mechanisms of action.
Rojas M; Rodríguez Y; Monsalve DM; Acosta-Ampudia Y; Camacho B; Gallo JE; Rojas-Villarraga A; Ramírez-Santana C; Díaz-Coronado JC; Manrique R; Mantilla RD; Shoenfeld Y; Anaya JM
Autoimmun Rev; 2020 Jul; 19(7):102554. PubMed ID: 32380316
[TBL] [Abstract][Full Text] [Related]
27. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.
Zhang L; Pang R; Xue X; Bao J; Ye S; Dai Y; Zheng Y; Fu Q; Hu Z; Yi Y
Aging (Albany NY); 2020 Apr; 12(8):6536-6542. PubMed ID: 32320384
[TBL] [Abstract][Full Text] [Related]
28. Convalescent plasma therapy in patients with COVID-19.
Yiğenoğlu TN; Hacıbekiroğlu T; Berber İ; Dal MS; Baştürk A; Namdaroğlu S; Korkmaz S; Ulas T; Dal T; Erkurt MA; Turgut B; Altuntaş F
J Clin Apher; 2020 Aug; 35(4):367-373. PubMed ID: 32643200
[TBL] [Abstract][Full Text] [Related]
29. Convalescent Plasma Therapy for COVID-19: State of the Art.
Focosi D; Anderson AO; Tang JW; Tuccori M
Clin Microbiol Rev; 2020 Sep; 33(4):. PubMed ID: 32792417
[TBL] [Abstract][Full Text] [Related]
30. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
[TBL] [Abstract][Full Text] [Related]
31. Vaccines, convalescent plasma, and monoclonal antibodies for covid-19.
Sewell HF; Agius RM; Kendrick D; Stewart M
BMJ; 2020 Jul; 370():m2722. PubMed ID: 32646867
[No Abstract] [Full Text] [Related]
32. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.
Ahn JY; Sohn Y; Lee SH; Cho Y; Hyun JH; Baek YJ; Jeong SJ; Kim JH; Ku NS; Yeom JS; Roh J; Ahn MY; Chin BS; Kim YS; Lee H; Yong D; Kim HO; Kim S; Choi JY
J Korean Med Sci; 2020 Apr; 35(14):e149. PubMed ID: 32281317
[TBL] [Abstract][Full Text] [Related]
33. Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects.
Sharun K; Tiwari R; Iqbal Yatoo M; Patel SK; Natesan S; Dhama J; Malik YS; Harapan H; Singh RK; Dhama K
Expert Opin Biol Ther; 2020 Sep; 20(9):1033-1046. PubMed ID: 32744917
[TBL] [Abstract][Full Text] [Related]
34. Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic.
Dassarma B; Tripathy S; Matsabisa M
Transfus Clin Biol; 2021 Feb; 28(1):123-127. PubMed ID: 33285298
[TBL] [Abstract][Full Text] [Related]
35. Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?
Xi Y
Signal Transduct Target Ther; 2020 Sep; 5(1):203. PubMed ID: 32934211
[No Abstract] [Full Text] [Related]
36. INFUSION OF CONVALESCENT PLASMA IS ASSOCIATED WITH CLINICAL IMPROVEMENT IN CRITICALLY ILL PATIENTS WITH COVID-19: A PILOT STUDY.
Olivares-Gazca JC; Priesca-Marín JM; Ojeda-Laguna M; Garces-Eisele J; Soto-Olvera S; Palacios-Alonso A; Izquierdo-Vega J; Chacon-Cano R; Arizpe-Bravo D; López-Trujillo MA; Cantero-Fortiz Y; Fernandez-Lara D; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
Rev Invest Clin; 2020; 72(3):159-164. PubMed ID: 32584322
[TBL] [Abstract][Full Text] [Related]
37. How did we rapidly implement a convalescent plasma program?
Budhai A; Wu AA; Hall L; Strauss D; Paradiso S; Alberigo J; Hillyer CD; Jett B; Tobian AAR; Bloch EM; Sachais BS; Shaz BH
Transfusion; 2020 Jul; 60(7):1348-1355. PubMed ID: 32449169
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 and SARS Coronavirus 2: Antibodies for the Immediate Rescue and Recovery Phase.
Halstead SB; Akkina R
Front Immunol; 2020; 11():1196. PubMed ID: 32574267
[No Abstract] [Full Text] [Related]
39. COVID-19 Vaccine: A comprehensive status report.
Kaur SP; Gupta V
Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
[TBL] [Abstract][Full Text] [Related]
40. Convalescent plasma treatment for COVID-19: Tempering expectations with the influenza experience.
Subbarao K; Mordant F; Rudraraju R
Eur J Immunol; 2020 Oct; 50(10):1447-1453. PubMed ID: 32886952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]